Parkinson's disease or dementia with Lewy bodies

There is 1 paper on Parkinson's disease or dementia with Lewy bodies in aging research: 1 observational study in people. The newest story, Nov 9, 2026: “Diabetes drug may offer symptom benefits in Parkinson’s trial”.

Disease

1 paper studies it34 more mention it1 finding

1 new paper in 30 daysSee all 35 papers on Parkinson's disease or dementia with Lewy bodies

“When adjusted for age and gender, Cox hazards analysis revealed that the CAS-J score significantly predicted phenoconversion to PD or DLB (hazard ratio: 5.9, 95 % confidence interval: 1.8-19.1, p = 0.003).”
Bowel movement frequency and difficult defecation using constipation assessment scale in patients with isolated REM sleep behavior disorderClinical parkinsonism & related disorders2024doi:10.1016/j.prdoa.2024.100269
  • Humans1

Associations

1

Constipation Assessment Scale Japanese version score

upin humans1HR 5.9

1 study
  1. Constipation Assessment Scale Japanese version score predicts Parkinson's disease or dementia with Lewy bodies in humans (isolated rapid eye movement sleep behavior disorder) (HR 5.9, 95% CI 1.8-19.1, p = 0.003).

    “When adjusted for age and gender, Cox hazards analysis revealed that the CAS-J score significantly predicted phenoconversion to PD or DLB (hazard ratio: 5.9, 95 % confidence interval: 1.8-19.1, p = 0.003).”

    Humansisolated rapid eye movement sleep behavior disorder

    Bowel movement frequency and difficult defecation using constipation assessment scale in patients with isolated REM sleep behavior disorder

    Clinical parkinsonism & related disorders

More on Constipation Assessment Scale Japanese version score

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 0Mar 2026: 0Apr 2026: 2May 2026: 4Jun 2026: 0Jul 2026: 1Aug 2026: 3Sep 2026: 1Oct 2026: 0Nov 2026: 014 papers in 12 months
Frontiers in Neurology

Diabetes drug may offer symptom benefits in Parkinson’s trial

A four-week randomized trial in 12 people found symptom-score changes differed across two diabetes drugs and placebo, with more favorable trends for dapagliflozin.A four-week randomized trial in 12 people found symptom-score changes differed across two diabetes drugs and placebo, with more favorable trends for dapagliflozin.

Randomized trial · 12 peopleParkinson's disease

See all 35 papers on Parkinson's disease or dementia with Lewy bodies